Intravesical Mycobacterial Cell Wall-DNA Complex in the Treatment of Carcinoma In Situ of the Bladder After Standard Intravesical Therapy Has Failed
To access this article, please choose from the options below
Study received research ethics committee approval from each participating site.
Supported by grants from Bioniche Life Sciences Inc (Belleville, Ontario, Canada).
For other articles on related topics see pages 1361, 1372 and 1381.
PII: S0022-5347(08)03046-2
doi:10.1016/j.juro.2008.11.019
© 2009 American Urological Association. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Response of Bladder Carcinoma Cells to TRAIL and Antisense Oligonucleotide, Bcl-2 or Clusterin Treatments , 20 January 2009
- MicroRNA-143 as a Tumor Suppressor for Bladder Cancer , 20 January 2009
- Preventing Bladder Tumor Implantation With Photodynamic Therapy in a Rat Model Mimicking Post-Fluorescence Guided Transurethral Resection , 20 January 2009

